The clearance builds on the initial approval of AISight Dx (Novo) in 2022.
PHILADELPHIA--(BUSINESS WIRE)--Proscia®, a leading provider of AI-enabled digital pathology solutions, today announced that UNITY Biotechnology, Inc., a company developing therapeutics to extend ...
NEW YORK & VISTA, Calif.--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, and Leica Biosystems, a cancer diagnostics company and global ...
Visiopharm's quantitative image analysis software suite uniquely offers a secure, scalable, agnostic platform that helps pathologists and researchers alike address the quality and cost challenges in ...